CN Stock MarketDetailed Quotes

300636 Jiangxi Synergy Pharmaceutical

Watchlist
  • 7.90
  • +0.27+3.54%
Trading Aug 30 13:43 CST
3.33BMarket Cap28.11P/E (TTM)

Jiangxi Synergy Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
0.08%382.05M
-6.47%206.45M
0.31%722.14M
5.94%559.66M
13.63%381.75M
22.79%220.75M
21.58%719.91M
23.43%528.27M
21.06%335.98M
30.89%179.77M
Operating revenue
0.08%382.05M
-6.47%206.45M
0.31%722.14M
5.94%559.66M
13.63%381.75M
22.79%220.75M
21.58%719.91M
23.43%528.27M
21.06%335.98M
30.89%179.77M
Other operating revenue
-88.54%398.4K
----
8.95%1.43M
----
668.20%3.48M
----
-56.93%1.32M
----
-83.57%452.38K
----
Total operating cost
-9.61%295.17M
-15.81%150.66M
-1.47%599.9M
5.31%476.32M
10.93%326.54M
19.92%178.96M
21.95%608.85M
27.42%452.32M
28.55%294.37M
30.98%149.24M
Operating cost
-1.71%250.14M
-7.61%130.75M
-0.99%481.66M
2.98%384.57M
5.42%254.5M
13.57%141.52M
17.71%486.45M
24.93%373.42M
23.26%241.43M
27.04%124.61M
Operating tax surcharges
94.30%3.39M
-1.19%859.07K
53.22%3.66M
58.28%2.8M
50.19%1.75M
46.32%869.46K
31.48%2.39M
28.99%1.77M
28.90%1.16M
35.76%594.21K
Operating expense
6.96%12.66M
11.80%5.93M
42.15%26.26M
41.43%17.56M
30.28%11.84M
4.76%5.3M
2.45%18.47M
-6.62%12.42M
18.56%9.09M
25.72%5.06M
Administration expense
-8.43%17.44M
-7.32%8.4M
4.95%34.57M
32.33%27.96M
48.03%19.05M
37.58%9.06M
38.59%32.94M
39.76%21.13M
37.54%12.87M
45.50%6.59M
Financial expense
-1,316.80%-10.65M
-285.55%-5.57M
-222.29%-9.4M
-277.69%-4.04M
-78.79%875.1K
235.71%3M
128.49%7.69M
15.74%2.28M
643.10%4.13M
2,087.68%893.86K
-Interest expense (Financial expense)
102.02%8.91M
182.30%4.06M
28.53%9.9M
103.36%6.17M
24.43%4.41M
-17.67%1.44M
35.31%7.7M
-22.55%3.03M
34.25%3.55M
35.72%1.75M
-Interest Income (Financial expense)
-491.96%-16.22M
-716.97%-9.01M
-488.68%-17.01M
-333.72%-8.9M
-113.17%-2.74M
-122.64%-1.1M
-48.24%-2.89M
-86.79%-2.05M
-48.65%-1.29M
19.01%-495.57K
Research and development
-42.43%22.18M
-46.42%10.29M
3.68%63.15M
14.94%47.48M
49.93%38.53M
67.09%19.21M
56.10%60.91M
69.82%41.31M
75.53%25.7M
68.35%11.5M
Credit Impairment Loss
-391.26%-1.99M
-61.14%-2.53M
107.24%107.34K
-4.29%-1.47M
14.33%-404.71K
-20.41%-1.57M
28.18%-1.48M
12.45%-1.41M
85.27%-472.4K
38.77%-1.3M
Asset Impairment Loss
-377.25%-11.91M
-42.35%-7.92M
-162.12%-19.14M
-132.09%-993.64K
-192.21%-2.5M
---5.56M
-52.53%-7.3M
--3.1M
--2.71M
----
Other net revenue
-263.55%-9.68M
0.06%-6.76M
-111.91%-10.01M
60.17%5.88M
64.22%5.92M
-593.16%-6.77M
-4.62%-4.72M
508.91%3.67M
332.55%3.6M
26.85%-975.98K
Fair value change income
----
----
----
----
----
----
-200.00%-255.58K
---481.44K
---566K
----
Invest income
---45.88K
----
159.55%567.88K
----
----
----
-4,832.31%-953.63K
-3,696.51%-724.75K
-1,461.92%-274.45K
----
Asset deal income
---706.14K
--0
-650.05%-1.32M
-404.46%-888.31K
----
--0
82.48%-176.09K
-23.50%-176.09K
----
----
Other revenue
-43.52%4.98M
904.91%3.69M
79.50%9.78M
174.18%9.23M
299.35%8.82M
12.58%366.76K
77.55%5.45M
44.02%3.37M
30.32%2.21M
-58.25%325.79K
Operating profit
26.29%77.21M
40.02%49.03M
5.55%112.23M
12.05%89.22M
35.22%61.13M
18.48%35.02M
20.37%106.33M
8.16%79.63M
-3.80%45.21M
33.92%29.56M
Add:Non operating Income
----
--0
1,490.37%354.08K
-69.79%6.73K
-69.79%6.73K
-69.79%6.73K
3,008,548.65%22.26K
3,008,548.65%22.26K
3,008,548.65%22.26K
--22.26K
Less:Non operating expense
1.15%66.75K
1.15%66.75K
-58.05%85.99K
19.98%65.99K
19.98%65.99K
19.98%65.99K
--205K
--55K
--55K
--55K
Total profit
26.31%77.14M
40.07%48.97M
5.98%112.5M
12.02%89.16M
35.18%61.07M
18.41%34.96M
20.16%106.15M
8.12%79.59M
-3.86%45.18M
33.78%29.52M
Less:Income tax cost
87.69%7.59M
190.08%5.4M
18.88%6.52M
105.76%10.51M
59.18%4.04M
-30.91%1.86M
-24.08%5.48M
-27.78%5.11M
-43.12%2.54M
39.52%2.7M
Net profit
21.96%69.55M
31.62%43.56M
5.28%105.98M
5.59%78.65M
33.75%57.03M
23.36%33.1M
24.10%100.67M
11.93%74.49M
0.26%42.64M
33.22%26.83M
Net profit from continuing operation
21.96%69.55M
----
5.28%105.98M
5.59%78.65M
33.75%57.03M
----
24.10%100.67M
11.93%74.49M
0.26%42.64M
33.22%26.83M
Net profit of parent company owners
21.96%69.55M
31.62%43.56M
5.28%105.98M
5.59%78.65M
33.75%57.03M
23.36%33.1M
24.10%100.67M
11.93%74.49M
0.26%42.64M
33.22%26.83M
Earning per share
Basic earning per share
2.16%0.1656
9.74%0.1037
-9.66%0.2786
-7.47%0.2143
18.93%0.1621
8.75%0.0945
17.40%0.3084
5.27%0.2316
-34.03%0.1363
-11.24%0.0869
Diluted earning per share
2.35%0.1656
10.44%0.1037
-4.20%0.2786
-7.43%0.2144
28.31%0.1618
18.41%0.0939
21.02%0.2908
15.80%0.2316
-33.21%0.1261
-19.00%0.0793
Other composite income
Total composite income
21.96%69.55M
31.62%43.56M
5.28%105.98M
5.59%78.65M
33.75%57.03M
23.36%33.1M
24.10%100.67M
11.93%74.49M
0.26%42.64M
33.22%26.83M
Total composite income of parent company owners
21.96%69.55M
31.62%43.56M
5.28%105.98M
5.59%78.65M
33.75%57.03M
23.36%33.1M
24.10%100.67M
11.93%74.49M
0.26%42.64M
33.22%26.83M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 0.08%382.05M-6.47%206.45M0.31%722.14M5.94%559.66M13.63%381.75M22.79%220.75M21.58%719.91M23.43%528.27M21.06%335.98M30.89%179.77M
Operating revenue 0.08%382.05M-6.47%206.45M0.31%722.14M5.94%559.66M13.63%381.75M22.79%220.75M21.58%719.91M23.43%528.27M21.06%335.98M30.89%179.77M
Other operating revenue -88.54%398.4K----8.95%1.43M----668.20%3.48M-----56.93%1.32M-----83.57%452.38K----
Total operating cost -9.61%295.17M-15.81%150.66M-1.47%599.9M5.31%476.32M10.93%326.54M19.92%178.96M21.95%608.85M27.42%452.32M28.55%294.37M30.98%149.24M
Operating cost -1.71%250.14M-7.61%130.75M-0.99%481.66M2.98%384.57M5.42%254.5M13.57%141.52M17.71%486.45M24.93%373.42M23.26%241.43M27.04%124.61M
Operating tax surcharges 94.30%3.39M-1.19%859.07K53.22%3.66M58.28%2.8M50.19%1.75M46.32%869.46K31.48%2.39M28.99%1.77M28.90%1.16M35.76%594.21K
Operating expense 6.96%12.66M11.80%5.93M42.15%26.26M41.43%17.56M30.28%11.84M4.76%5.3M2.45%18.47M-6.62%12.42M18.56%9.09M25.72%5.06M
Administration expense -8.43%17.44M-7.32%8.4M4.95%34.57M32.33%27.96M48.03%19.05M37.58%9.06M38.59%32.94M39.76%21.13M37.54%12.87M45.50%6.59M
Financial expense -1,316.80%-10.65M-285.55%-5.57M-222.29%-9.4M-277.69%-4.04M-78.79%875.1K235.71%3M128.49%7.69M15.74%2.28M643.10%4.13M2,087.68%893.86K
-Interest expense (Financial expense) 102.02%8.91M182.30%4.06M28.53%9.9M103.36%6.17M24.43%4.41M-17.67%1.44M35.31%7.7M-22.55%3.03M34.25%3.55M35.72%1.75M
-Interest Income (Financial expense) -491.96%-16.22M-716.97%-9.01M-488.68%-17.01M-333.72%-8.9M-113.17%-2.74M-122.64%-1.1M-48.24%-2.89M-86.79%-2.05M-48.65%-1.29M19.01%-495.57K
Research and development -42.43%22.18M-46.42%10.29M3.68%63.15M14.94%47.48M49.93%38.53M67.09%19.21M56.10%60.91M69.82%41.31M75.53%25.7M68.35%11.5M
Credit Impairment Loss -391.26%-1.99M-61.14%-2.53M107.24%107.34K-4.29%-1.47M14.33%-404.71K-20.41%-1.57M28.18%-1.48M12.45%-1.41M85.27%-472.4K38.77%-1.3M
Asset Impairment Loss -377.25%-11.91M-42.35%-7.92M-162.12%-19.14M-132.09%-993.64K-192.21%-2.5M---5.56M-52.53%-7.3M--3.1M--2.71M----
Other net revenue -263.55%-9.68M0.06%-6.76M-111.91%-10.01M60.17%5.88M64.22%5.92M-593.16%-6.77M-4.62%-4.72M508.91%3.67M332.55%3.6M26.85%-975.98K
Fair value change income -------------------------200.00%-255.58K---481.44K---566K----
Invest income ---45.88K----159.55%567.88K-------------4,832.31%-953.63K-3,696.51%-724.75K-1,461.92%-274.45K----
Asset deal income ---706.14K--0-650.05%-1.32M-404.46%-888.31K------082.48%-176.09K-23.50%-176.09K--------
Other revenue -43.52%4.98M904.91%3.69M79.50%9.78M174.18%9.23M299.35%8.82M12.58%366.76K77.55%5.45M44.02%3.37M30.32%2.21M-58.25%325.79K
Operating profit 26.29%77.21M40.02%49.03M5.55%112.23M12.05%89.22M35.22%61.13M18.48%35.02M20.37%106.33M8.16%79.63M-3.80%45.21M33.92%29.56M
Add:Non operating Income ------01,490.37%354.08K-69.79%6.73K-69.79%6.73K-69.79%6.73K3,008,548.65%22.26K3,008,548.65%22.26K3,008,548.65%22.26K--22.26K
Less:Non operating expense 1.15%66.75K1.15%66.75K-58.05%85.99K19.98%65.99K19.98%65.99K19.98%65.99K--205K--55K--55K--55K
Total profit 26.31%77.14M40.07%48.97M5.98%112.5M12.02%89.16M35.18%61.07M18.41%34.96M20.16%106.15M8.12%79.59M-3.86%45.18M33.78%29.52M
Less:Income tax cost 87.69%7.59M190.08%5.4M18.88%6.52M105.76%10.51M59.18%4.04M-30.91%1.86M-24.08%5.48M-27.78%5.11M-43.12%2.54M39.52%2.7M
Net profit 21.96%69.55M31.62%43.56M5.28%105.98M5.59%78.65M33.75%57.03M23.36%33.1M24.10%100.67M11.93%74.49M0.26%42.64M33.22%26.83M
Net profit from continuing operation 21.96%69.55M----5.28%105.98M5.59%78.65M33.75%57.03M----24.10%100.67M11.93%74.49M0.26%42.64M33.22%26.83M
Net profit of parent company owners 21.96%69.55M31.62%43.56M5.28%105.98M5.59%78.65M33.75%57.03M23.36%33.1M24.10%100.67M11.93%74.49M0.26%42.64M33.22%26.83M
Earning per share
Basic earning per share 2.16%0.16569.74%0.1037-9.66%0.2786-7.47%0.214318.93%0.16218.75%0.094517.40%0.30845.27%0.2316-34.03%0.1363-11.24%0.0869
Diluted earning per share 2.35%0.165610.44%0.1037-4.20%0.2786-7.43%0.214428.31%0.161818.41%0.093921.02%0.290815.80%0.2316-33.21%0.1261-19.00%0.0793
Other composite income
Total composite income 21.96%69.55M31.62%43.56M5.28%105.98M5.59%78.65M33.75%57.03M23.36%33.1M24.10%100.67M11.93%74.49M0.26%42.64M33.22%26.83M
Total composite income of parent company owners 21.96%69.55M31.62%43.56M5.28%105.98M5.59%78.65M33.75%57.03M23.36%33.1M24.10%100.67M11.93%74.49M0.26%42.64M33.22%26.83M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg